Sunday – Thursday : 8:00 – 17:00
en_US English
Call Us Now:
0244891235
🔍

Diflustero Launch Event

Orchidia pharmaceutical Ind. launched Diflustero, which is the first difluprednate ophthalmic emulsion form in Egypt for treatment of Ocular inflammation and the first FDA approved for treatment of inflammation and pain associated with ocular surgeries and anterior uveitis.

Diflustero launch event was an integrated scientific day that includes a series of interactive topics and articles with an innovative design to ensure two-way communication, discussions, and challenges.

The symposium offered an opportunity for some great speakers and professors like Prof. Ioannis G. Pallikaris “The father of LASIK Surgery”, Prof. Osama Ibrahim “ Clinical professor of ophthalmology & immediate past president of Alexandria University , and Dr. Alaa El-Danasoury “ Chief Medical Officer and Director of Cornea & Refractive surgery units of the Maghraby Hospitals & Centers “ to give speeches that encourage a free-flowing exchange of ideas and practical solutions that were very useful in improving patient’s outcome.

Read More
Categories:

Orchidia pharmaceutical Ind. launched Diflustero, which is the first difluprednate ophthalmic emulsion form in Egypt for treatment of Ocular inflammation and the first FDA approved for

Related products

No products in the cart.